• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见的网膜浸润性前列腺癌病例:PSMA PET/CT 成像分期和全身治疗反应。

A Rare Case of Omentum Invasive Prostate Cancer: Staging With PSMA PET/CT Imaging and Response to Systemic Therapy.

机构信息

From the *Princess Alexandra Hospital; †School of Medicine, University of Queensland; and ‡Queensland University of Technology, Brisbane, Australia.

出版信息

Clin Nucl Med. 2017 Jun;42(6):e311-e312. doi: 10.1097/RLU.0000000000001619.

DOI:10.1097/RLU.0000000000001619
PMID:28240670
Abstract

The omentum is a rare metastatic site for prostatic adenocarcinoma. We present a case of metastatic castrate-resistant prostate cancer, with progressive omentum invasive prostate cancer identified on prostate-specific membrane antigen (PSMA) PET/CT scan. Omental biopsy revealed metastatic prostate adenocarcinoma, and cabazitaxel chemotherapy was instituted with a prostate-specific antigen biochemical response. Repeat PSMA PET/CT imaging revealed increased avidity in omental metastasis. Despite prostate-specific antigen response, PSMA PET/CT did not correlate with a therapeutic response.

摘要

网膜是前列腺腺癌罕见的转移部位。我们报告一例转移性去势抵抗性前列腺癌,前列腺特异性膜抗原(PSMA)PET/CT 扫描显示进行性网膜侵袭性前列腺癌。网膜活检显示转移性前列腺腺癌,给予卡巴他赛化疗,前列腺特异性抗原生化反应得到改善。重复 PSMA PET/CT 成像显示网膜转移灶摄取增加。尽管前列腺特异性抗原有反应,但 PSMA PET/CT 与治疗反应无相关性。

相似文献

1
A Rare Case of Omentum Invasive Prostate Cancer: Staging With PSMA PET/CT Imaging and Response to Systemic Therapy.罕见的网膜浸润性前列腺癌病例:PSMA PET/CT 成像分期和全身治疗反应。
Clin Nucl Med. 2017 Jun;42(6):e311-e312. doi: 10.1097/RLU.0000000000001619.
2
Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CT.前列腺特异性膜抗原 PET/CT 中表现为腹膜转移的脾种植,经脾脏 SPECT/CT 选择性检查得以确诊。
Clin Nucl Med. 2017 Dec;42(12):e504-e505. doi: 10.1097/RLU.0000000000001878.
3
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.一项前瞻性随机多中心研究,评估镓-68 前列腺特异性膜抗原(PSMA)PET/CT 成像在根治性手术或放疗前对高危前列腺癌分期的影响(proPSMA 研究):临床试验方案。
BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.
4
Early Detection of Bilateral Testicular Metastases From Prostatic Adenocarcinoma Using 68Ga-PSMA Ligand PET/CT.使用 68Ga-PSMA 配体 PET/CT 早期检测前列腺腺癌的双侧睾丸转移。
Clin Nucl Med. 2017 Jul;42(7):563-564. doi: 10.1097/RLU.0000000000001659.
5
PSMA PET and Radionuclide Therapy in Prostate Cancer.前列腺癌中的前列腺特异性膜抗原正电子发射断层扫描与放射性核素治疗
Semin Nucl Med. 2016 Nov;46(6):522-535. doi: 10.1053/j.semnuclmed.2016.07.006. Epub 2016 Sep 3.
6
Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria.PSMA PET/CT 影像学检查时的全身治疗反应评估标准建议:PSMA PET 进展标准。
J Nucl Med. 2020 May;61(5):678-682. doi: 10.2967/jnumed.119.233817. Epub 2019 Dec 5.
7
Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.前列腺特异性膜抗原PET成像在前列腺癌中的当前应用及未来展望
Q J Nucl Med Mol Imaging. 2019 Mar;63(1):7-18. doi: 10.23736/S1824-4785.18.03059-5. Epub 2018 Mar 8.
8
Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer.前列腺特异性膜抗原 PET/计算机断层扫描在前列腺癌分期中的应用。
Curr Opin Urol. 2020 Sep;30(5):628-634. doi: 10.1097/MOU.0000000000000799.
9
Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT.骨梗死酷似骨转移:18F-前列腺特异性膜抗原 PET/CT 表现
Clin Nucl Med. 2021 May 1;46(5):e250-e252. doi: 10.1097/RLU.0000000000003455.
10
Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.前列腺特异性膜抗原 PET:在前列腺癌中的临床应用、正常表现、要点和陷阱。
Radiographics. 2018 Jan-Feb;38(1):200-217. doi: 10.1148/rg.2018170108.

引用本文的文献

1
A Case Report of a Patient With Prostate Adenocarcinoma Metastatic to the Posterior Peritoneum Despite the Negative Preoperative Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Scan.一例术前前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算机断层扫描(PET/CT)显示阴性但已发生后腹膜转移的前列腺腺癌患者的病例报告。
Cureus. 2023 Jun 4;15(6):e39948. doi: 10.7759/cureus.39948. eCollection 2023 Jun.
2
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series.机器人辅助根治性前列腺切除术治疗腹膜转移癌:病例系列研究。
Urology. 2022 Sep;167:171-178. doi: 10.1016/j.urology.2022.04.002. Epub 2022 Apr 25.
3
Isolated peritoneal carcinomatosis in prostate cancer: from a successful hormonal management to a review of the literature.
前列腺癌孤立性腹膜癌转移:从成功的激素治疗到文献综述
Future Sci OA. 2021 Apr 30;7(6):FSO707. doi: 10.2144/fsoa-2021-0009.
4
What are the odds? Prostate metastases to ureter and peritoneum.几率有多大?前列腺转移至输尿管和腹膜。
BMJ Case Rep. 2018 Aug 16;2018:bcr-2018-225730. doi: 10.1136/bcr-2018-225730.